To further determine the selectivity for MMR deficiency, we analyzed the cell viability of human MutL homologue 1 (hMLH1)-deficient (MMR–) and hMLH1-proficient (MMR+) RKO human colon carcinoma cell lines. The gene discussed is MRC1; the disease is colon carcinoma.